» Articles » PMID: 26509439

CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in MiR-202-3p

Overview
Journal PLoS One
Date 2015 Oct 29
PMID 26509439
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Bi-directional communication with the microenvironment is essential for homing and survival of cancer cells with implications for disease biology and behaviour. In chronic lymphocytic leukemia (CLL), the role of the microenvironment on malignant cell behaviour is well described. However, how CLL cells engage and recruit nurturing cells is poorly characterised. Here we demonstrate that CLL cells secrete exosomes that are nanovesicles originating from the fusion of multivesicular bodies with the plasma membrane, to shuttle proteins, lipids, microRNAs (miR) and mRNAs to recipient cells. We characterise and confirm the size (50-100 nm) and identity of the CLL-derived exosomes by Electron microscopy (EM), Atomic force microscopy (AFM), flow cytometry and western blotting using both exosome- and CLL-specific markers. Incubation of CLL-exosomes, derived either from cell culture supernatants or from patient plasma, with human stromal cells shows that they are readily taken up into endosomes, and induce expression of genes such as c-fos and ATM as well as enhance proliferation of recipient HS-5 cells. Furthermore, we show that CLL exosomes encapsulate abundant small RNAs and are enriched in certain miRs and specifically hsa-miR-202-3p. We suggest that such specific packaging of miR-202-3p into exosomes results in enhanced expression of 'suppressor of fused' (Sufu), a Hedgehog (Hh) signalling intermediate, in the parental CLL cells. Thus, our data show that CLL cells secrete exosomes that alter the transcriptome and behaviour of recipient cells. Such communication with microenvironment is likely to have an important role in CLL disease biology.

Citing Articles

Potential Use of Exosomal Non-Coding MicroRNAs in Leukemia Therapy: A Systematic Review.

Gil-Kulik P, Kluz N, Przywara D, Petniak A, Wasilewska M, Fraczek-Chudzik N Cancers (Basel). 2024; 16(23).

PMID: 39682135 PMC: 11639955. DOI: 10.3390/cancers16233948.


The theragnostic advances of exosomes in managing leukaemia.

Ghosh S, Dey A, Chakrabarti A, Bhuniya T, Indu N, Hait A J Cell Mol Med. 2024; 28(23):e70052.

PMID: 39659020 PMC: 11632122. DOI: 10.1111/jcmm.70052.


Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo.

Ikhlef L, Ratti N, Durand S, Formento R, Daverat H, Boutaud M Cancer Gene Ther. 2024; 31(8):1164-1176.

PMID: 38918490 PMC: 11327105. DOI: 10.1038/s41417-024-00802-7.


The Role of Extracellular Vesicles in the Pathogenesis of Hematological Malignancies: Interaction with Tumor Microenvironment; a Potential Biomarker and Targeted Therapy.

Das K, Mukherjee T, Shankar P Biomolecules. 2023; 13(6).

PMID: 37371477 PMC: 10296653. DOI: 10.3390/biom13060897.


Extracellular Vesicles in Chronic Lymphocytic Leukemia: Tumor Microenvironment Messengers as a Basis for New Targeted Therapies?.

Dubois K, Tannoury M, Bauvois B, Susin S, Garnier D Cancers (Basel). 2023; 15(8).

PMID: 37190234 PMC: 10137283. DOI: 10.3390/cancers15082307.


References
1.
Roccaro A, Sacco A, Maiso P, Azab A, Tai Y, Reagan M . BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest. 2013; 123(4):1542-55. PMC: 3613927. DOI: 10.1172/JCI66517. View

2.
Thery C . Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep. 2011; 3:15. PMC: 3155154. DOI: 10.3410/B3-15. View

3.
Denzer K, Kleijmeer M, Heijnen H, Stoorvogel W, Geuze H . Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci. 2000; 113 Pt 19:3365-74. DOI: 10.1242/jcs.113.19.3365. View

4.
Ferrajoli A, Shanafelt T, Ivan C, Shimizu M, Rabe K, Nouraee N . Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood. 2013; 122(11):1891-9. PMC: 3779381. DOI: 10.1182/blood-2013-01-478222. View

5.
Clayton A, COURT J, Navabi H, Adams M, Mason M, Hobot J . Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods. 2001; 247(1-2):163-74. DOI: 10.1016/s0022-1759(00)00321-5. View